Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

P3 Health Partners (PIIIW) EPS (Weighted Average and Diluted) (2022 - 2025)

P3 Health Partners' EPS (Weighted Average and Diluted) history spans 4 years, with the latest figure at -$23.08 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) fell 5.44% year-over-year to -$23.08; the TTM value through Dec 2025 reached -$45.26, up 14.31%, while the annual FY2025 figure was -$45.26, 16.28% up from the prior year.
  • EPS (Weighted Average and Diluted) reached -$23.08 in Q4 2025 per PIIIW's latest filing, down from -$9.67 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.09 in Q2 2023 to a low of -$23.08 in Q4 2025.
  • Average EPS (Weighted Average and Diluted) over 4 years is -$6.58, with a median of -$4.98 recorded in 2025.
  • Peak YoY movement for EPS (Weighted Average and Diluted): skyrocketed 97.59% in 2023, then tumbled 12983.33% in 2024.
  • A 4-year view of EPS (Weighted Average and Diluted) shows it stood at -$2.23 in 2022, then skyrocketed by 90.13% to -$0.22 in 2023, then plummeted by 9850.0% to -$21.89 in 2024, then dropped by 5.44% to -$23.08 in 2025.
  • Per Business Quant, the three most recent readings for PIIIW's EPS (Weighted Average and Diluted) are -$23.08 (Q4 2025), -$9.67 (Q3 2025), and -$6.23 (Q2 2025).